Objective: To determine the value of fetal fibronectin (FFN), cervical length (CL) measurement and their combination as binary predictors for preterm birth (PB) in women with preterm labour (PTL) between 24 + 0 and 34 + 0 weeks. Methods: One hundred fifty-nine patients with signs of PTL (singleton pregnancies (SP) = 125, twin pregnancies (TP) = 34) were evaluated in a retrospective study. Inclusion criteria were contractions > 4/20 min, intact membranes, no bleeding. The cut-off was ≥50 ng/ml for FFN and ≤20 mm for CL measured by transvaginal ultrasound. The primary outcome variable was delivery within 7 days from admission. Results: We evaluated 125 SPs and 34 TPs. In SPs, both methods had a sensitivity of 80%; the specificity was 82% for FFN, and 50% for CL. For the combination of both tests sensitivity was 80% and specificity 88%. In TPs, the sensitivity of both tests was lower (FFN 33%, CL 67%) but the combination of both tests represented the highest result for specificity (77% compared to 68% for FFN alone and 32% for CL alone). Conclusion: The combination of FFN and CL in PTL results in a significant higher specificity in SPs. In TPs the performance of the tests is less accurate.
Introduction
Preterm birth (PTB) is the leading cause of neonatal mortality and morbidity. Therefore, women presenting with signs of preterm labour (PTL) but intact membranes are often hospitalised and receive tocolytics and corticosteroids for lung maturation. The clinical diagnosis of PTL that precedes PTB has been characterised by its inaccuracy, with about two thirds of women presenting with PTL ultimately delivering at term. Correct identification of a mother at risk for a PTB allows risk specific treatment, stabilisation, and referral to a perinatal centre for achieving optimal neonatal outcome. It avoids otherwise unnecessary transport of the patient, potential harmful interventions and costly hospitalisations.
Several predictive markers have been proposed detecting women at risk for PTB. The biophysical sonographic measurement of cervical length (CL) and the biochemical assays for fetal fibronectin (FFN) appear to be the most promising and have been assessed in multiple studies [1] [2] .
FFN is a normal constituent of the extracellular matrix of the maternal-fetal interface. This high molecular weight glycoprotein seems to play an essential role in maintaining the integrity of the chorionic-decidual interface. It is accepted that the disruption of the maternal-fetal interface often precedes the onset of PTL and results in the release of FFN into the cervicovaginal fluid [2] [3] .
CL measurement is well established as a predictor for PTB at 20 weeks of gestation in asymptomatic women at increased risk [4] but less evaluated in symptomatic women with PTL using mostly thresholds below 15 mm or above 30 mm cervical length [5] . Short cervix reportedly predicts PTD with a sensitivity of 69% -83%, a specificity of 69% -88%, and a relatively low positive predictive value (PPV) of 22% -54% in symptomatic women.
The usefulness of both tests has been shown by improving the accuracy of diagnosis and in reducing unnecessary maternal interventions and transferral of patients to a tertiary center. Furthermore, they are easily to apply after minimal training, safe, well accepted by pregnant women and cost effective [6] - [9] .
There are, however, conflicting results from retrospective and observational studies, as well as from metaanalysis. Two Cochrane reviews have found no significant association between knowledge of CL results and a lower incidence of PTB, but for FFN an association between knowledge of FFN results and a lower incidence of PTB before 37 weeks was mentioned [10] [11] . Some authors found the combination not superior to either test alone, especially compared to CL measurement [3] [12] [13] and a recent meta-analysis found the cervicovaginal FFN assay to have limited accuracy in predicting PTB within 7 days of sampling in symptomatic pregnant women [14] .
The discordant results of these studies illustrate the predicament for the clinical routine situation. Furthermore, the studies use different cut-off values and different ranges of examined weeks of gestation, which makes them even more difficult to compare and interpret.
Our objective was to determine whether the combination of the two tests was superior to each test alone as a prediction of preterm birth within seven days in symptomatic women with singleton and twin pregnancies.
Methods
This was a retrospective study with reviewed case notes conducted at two Swiss tertiary centres (center A 2000 deliveries/year and center B 1300 deliveries/year) from [2005] [2006] [2007] [2008] . Included were patients with PTL (at least 4 contractions within 20 minutes), between 24 + 0 and 33 + 6 weeks of gestation with a twin or singleton pregnancy and who had a documented assessment of FFN and CL. Gestational age was confirmed by first trimester ultrasound. Exclusion criteria were preterm premature rupture of membranes, cervical dilation > 3 cm, cerclage, vaginal bleeding, vaginal examination or intercourse within 24 h before FFN measurement, intrauterine fetal demise, fetal malformation, intrauterine growth restriction < 5th percentile, preeclampsia, and uterine malformation. At presentation to the hospital FFN was collected during speculum examination from the posterior fornix and the qualitative detection of FFN (Quikcheck FFN, Hologic, Marlborough, MA, USA) was performed as a rapid qualitative bedside test, described by the manufacturer (http://www.ffntest.com/hcp/testing/quikcheck.html). Subsequently transvaginal ultrasound (using a 4 -8 MHz vaginal probe, Logiq or Voluson, GE healthcare or Alpha 5, Aloka) was carried out by the attending physician and CL was measured with an empty bladder as described in earlier publications and the shortest functional CL was used [15] .
The cut off values used were FFN ≥ 50 ng/ml and CL ≤ 20 mm on transvaginal ultrasound. The CL cut-off value of 20 mm was chosen, since it is commonly used in both singleton pregnancies (SP) and twin pregnancies (TP).
Results of the FFN tests were available to the attending clinicians who were free to use this information at their discretion for clinical management. However only CL was part of the local clinical management protocols, which physicians followed also with regard to the administration of tocolysis and corticosteroids for fetal lung maturation.
The primary outcome was the occurrence of PTB within 7 days (≤7 days) from admission. The two tests were evaluated separately as well as in combination, considering the combined test positive if both tests were positive ("AND" combination). As the management of preterm labor was not changed during the study period it was described as part of the assessment of the institutional quality of the service and therefore ethical approval was not obtained.
Patients with SP and with TP were analysed separately. Sensitivity, specificity and likelihood ratios, as well as positive and negative predictive values were computed, together with 95% confidence intervals (CI) according to Blaker 2000 and were tested with the McNemar-Test at a significance level of 0.05. The data were analysed using the statistical software R.
Results
A total of 159 patients were included, of which 125 were SPs and 34 TPs. They presented with PTL at a median age of gestation of 29 + 5 weeks and 29 + 1 weeks in SP and TP, respectively. Demographic characteristics of the women, which were comparable between singleton and twin pregnancies and the main pregnancy outcomes, are displayed in Table 1 . Figure 1 , the estimates are shown together with the corresponding 95% confidence interval.
In TP, the sensitivity of both tests was less (FFN 33% and CL 67%) compared to SPs, but again the combination of the two tests showed the highest result for specificity (77% compared to 68% for FFN alone and 32% for CL alone). (5) 50% (2) 69% (11) 43% (3) 2 0% (0) 25% (1) 12% (2) 29% (2) >2 29% (2) 25% (1) 19% (3) 29% ( Lung maturation 34 100% (7) 100% (4) 100% (16) 57% ( (Figure 2) .
The NPV was similar for both tests alone and the combination of the two. Likelihood ratios are demonstrated in Figure 3 and Figure 4 (in all figures the estimates are shown together with the corresponding 95% confidence interval). For the combined test women with a positive result received tocolytics in 100% compared to those with two negative tests (7.41%). Not only the rate for preterm birth within seven days was higher in this group but also the rate for PTB < 34 and <37 weeks.
Discussion
The findings of this study clearly demonstrate the advantage of the combined test of a positive FFN and a short CL for the identification of patients with true preterm labour. A very small part of women with SP and clinical symptoms of labor delivered within 7 days. Compared to the clinical assessment we had a modest but higher positive predictive value with the combination of FFN and CL and a high negative predictive value. For SPs the combination of both tests provides a better estimate of the risk of PTB within seven days and therefore could be integrated into the decision to hospitalize high risk women, use acute tocolysis and antenatal lung maturation or identify safely women at low risk and avoid overtreatment.
For TPs the combination also seems to be superior, but in the sense that if either test is positive hospitalisation should occur. This underlines furthermore the high-risk situation for PTB in twin pregnancies, but should be interpreted with caution due to the small numbers of TP.
In contrast to many other countries cervical ultrasound assessment is mostly always available 24 h in Swiss obstetric departments. The combination of both tests might be more expensive than one test alone, but the higher specificity and negative predictive value allows reducing costs from unnecessary interventions.
Because the etiology of preterm labor is multifactorial, using multiple biomarkers from distinct biologic pathways will better predict the risk of preterm labor. Furthermore, combining non-invasive tools such as a physical or ultrasound finding may improve the ability of specific biomarker in predicting outcome [16] .
Our findings concerning the properties of FFN and sonographic CL are in agreement with the previous reports considering the two tests in isolation [4] [8] [17] [18] . The results are in contrast to the study of Tsoi et al., where CL was the only significant contributor to the prediction of delivery within 7 days. FFN did not improve the prediction [12] . This prospective observational study, however, included women up to 36 weeks of gestation and 32% of the patients were of Afrocaribbean ethnicity. A limitation of our study is its retrospective nonrandomized design. In this context, a potential source of bias is represented by the fact that test results were available to clinicians and may have influenced clinical decision making. A possible indication in that direction is that patients with negative tests appear to have received tocolytics significantly less frequently. Although relatively small, our sample is one of the largest among published studies on this topic.
Conclusion
In singleton and twin pregnancies with PTL, both tests are significantly associated with a prediction of preterm birth within seven days. However, the combination of the FFN and sonographic CL in PTL outperforms either test. Our data suggest that a combination of FFN-testing and CL measurement is recommendable for singleton and twin pregnancies, but large prospective studies are needed too. There are a number of research projects and clinical trials currently underway in Europe evaluating the properties of these tests [19] .
